Track topics on Twitter Track topics that are important to you
Complete report $11,500. nbsp;DataPack test volumes, sales forecasts, supplier shares $7,500.
This comprehensive report contains 306 pages, 59 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry hospital, commercial and pointofcare/POC markets during the next five years. The report explores business and technological trends in the US hematology and flow cytometry markets; provides market share estimates, test volume forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers.
The report provides fiveyear volume and sales forecasts for over 40 hematology and flow cytometry procedures performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care centers, surgery centers, nursing homes, and birth centers.
New product development opportunities with significant market appeal.
Alternative market penetration strategies.
Potential market entry barriers and risks.
CBC + 5Part Differential, Manual Differential/Review, Hematocrit Automated, Manual, Hemoglobin Automated, Manual, Sedimentation Rate, Reticulocytes, WBC Automated, Manual, Platelets Automated, Manual, Bone Marrow Analysis, RBC, Eosinophils.
Flow Cytometry Tests
Cell Surface Markers CD4/CD8/Tamp;B Lymphocytes, CD34, Others, Chemotherapy Monitoring Leukemia/Lymphoma, Others, HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers.
Market Segmentation Analysis
Sales and market share estimates for leading suppliers of hematology and flow cytometry products.
Test and sales forecasts for over 40 procedures by individual test and market segment:
Physician Offices/Group Practices
Ambulatory Care Centers
Current and Emerging Products
Analysis of current and emerging hematology and flow cytometry tests.
Reagent and instrument sales forecasts by market segment.
Instrument placements and installed base by manufacturer and model.
Sales and market shares of reagent and instrument suppliers.
Assessment of current and emerging technologies, and their potential market applications.
Comprehensive lists of companies developing or marketing new technologies and products by test.
Extensive strategic profiles of major suppliers and emerging market entrants.
The companies analyzed in the report include:
nbsp;nbsp; Agilent Technologies
nbsp;nbsp; Beckman Coulter/Danaher
nbsp;nbsp; Becton Dickinson
nbsp;nbsp; Iris Diagnostics/Danaher
nbsp;nbsp; Nihon Kohden
nbsp;nbsp; OrthoClinical Diagnostics
Contains 306 pages and 59 tablesNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells. In vertebrates, it is composed of blo...
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...